Research & Development
Researchers find that prompt C. difficile testing could reduce hospital infection spread, morbidity
Hospital policies allowing nurses to independently initiate testing for the bacterium C. difficile could reduce infection spread and associated morbidity.
May 11, 2023
Experts urge hospitals to establish C. difficile prevention programs in updated guidance
The updated guidance identifies diagnostic stewardship for the appropriate use and interpretation of C. difficile tests as an essential practice.
April 12, 2023
What can Amazon teach healthcare about AI?
In her talk, Barzilay discussed the current AI landscape in healthcare, doled out advice, and dispelled some myths. Barzilay is the distinguished professor for AI and health AI at the Massachusetts Institute of Technology (MIT) School of Engineering.
September 26, 2021
Market for biomarker-based infectious disease tests to hit $15B
Biomarkers include more than 1,000 substances that serve as reagents, consumables, and/or test components for a number of medical-related diagnostic and research applications. Substances that detect and measure genetic changes in patient samples are also included in the sales statistics.
May 25, 2021
Luminex MRSA test clears FDA
The Aries MRSA assay tests directly for MRSA DNA from nasal swabs in patients at risk for nasal colonization. Clearance was granted on September 25 and announced by the company on October 1.
September 30, 2019
Meridian acquires GenePOC from Debiopharm
Through the deal, Meridian will gain GenePOC's revogene product for microbial testing, which incorporates polymerase chain reaction (PCR) techniques for rapid testing in cases where infectious diseases are suspected. The product is marketed in the U.S., Europe, and Canada.
April 30, 2019
How hospitals can clamp down on pricey panel tests for GI bugs
Researchers used an electronic health record (EHR) system with clinical decision-support (CDS) tools to educate clinicians and block questionable GIPP orders for patients hospitalized with diarrhea at the University of Nebraska Medical Center. This approach cut the rate of inappropriate testing by 46%, with estimated savings of $168,000 over 15 months, lead author Dr. Jasmine Marcelin and colleagues wrote.
April 25, 2019
Page 1 of 1